TPC
Takeda Pharmaceutical Company Portfolio holdings
AUM
$19.6M
This Quarter Return
+0.32%
1 Year Return
-13.61%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$26.6M
AUM Growth
+$26.6M
(-30%)
Cap. Flow
-$10.1M
Cap. Flow
% of AUM
-38.17%
Top 10 Holdings %
Top 10 Hldgs %
99.89%
Holding
12
New
2
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
Lyell Immunopharma
LYEL
|
$527K |
| 2 |
THRD
Third Harmonic Bio
THRD
|
$379K |
Top Sells
| 1 |
Wave Life Sciences
WVE
|
$11M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
HilleVax
HLVX
$105M
| $13.9M | 52.4% | 6,724,000 | – | – |
|
2
Ovid Therapeutics
OVID
$91M
| $7.01M | 26.4% | 7,531,996 | – | – |
|
3
Xilio Therapeutics
XLO
$36.3M
| $1.42M | 5.33% | 1,475,121 | – | – |
|
4
Equillium
EQ
$62.2M
| $1.37M | 5.15% | 1,824,977 | – | – |
|
5
Shattuck Labs
STTK
$47M
| $624K | 2.35% | 515,619 | – | – |
|
6
American Well
AMWL
$111M
| $564K | 2.12% | 77,733 | – | – |
|
|
7
Lyell Immunopharma
LYEL
$213M
| $527K | 1.98% | +823,317 | New | +$527K |
|
|
TSBX
8
DELISTED
Turnstone Biologics
TSBX
| $448K | 1.69% | 895,824 | – | – |
|
|
THRD
9
DELISTED
Third Harmonic Bio
THRD
| $379K | 1.43% | +36,835 | New | +$379K |
|
10
Rani Therapeutics
RANI
$24.4M
| $278K | 1.05% | 203,190 | – | – |
|
11
Standard BioTools
LAB
$481M
| $28.9K | 0.11% | 16,515 | – | – |
|
|
12
Wave Life Sciences
WVE
$1.53B
| – | – | -1,346,892 | Closed | -$11M |
|